RenalGuard Gets Capital Infusion To Push AKI-Prevention Device Into US
Executive Summary
RenalGuard Solutions has attracted $14.5m from investors and will use the funds to take its novel device, designed to prevent acute kidney injury following cardiac interventional procedures, into the US.